Trademark: 85732596
Status Date
Monday, June 20, 2016
Filing Date
Wednesday, September 19, 2012
Published for Opposition
Tuesday, March 19, 2013
Abandoned Date
Monday, June 20, 2016
5 (Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; (Based on 44(d) Priority Application) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives
Color is not claimed as a feature of the mark.
The wording "DGANTA" has no meaning in a foreign language.
Jun 20, 2016
Abandonment Notice Mailed - No Use Statement Filed
Jun 20, 2016
Abandonment - No Use Statement Filed
Nov 19, 2015
Notice Of Approval Of Extension Request E-Mailed
Nov 18, 2015
Extension 5 Granted
Nov 11, 2015
Extension 5 Filed
Nov 11, 2015
Teas Extension Received
May 26, 2015
Notice Of Approval Of Extension Request E-Mailed
May 23, 2015
Extension 4 Granted
May 12, 2015
Extension 4 Filed
May 12, 2015
Teas Extension Received
Nov 14, 2014
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2014
Extension 3 Granted
Nov 10, 2014
Extension 3 Filed
Nov 10, 2014
Teas Extension Received
May 15, 2014
Notice Of Approval Of Extension Request E-Mailed
May 14, 2014
Extension 2 Granted
Apr 24, 2014
Extension 2 Filed
May 13, 2014
Case Assigned To Intent To Use Paralegal
Apr 24, 2014
Teas Extension Received
Nov 9, 2013
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2013
Extension 1 Granted
Nov 7, 2013
Extension 1 Filed
Nov 7, 2013
Teas Extension Received
May 14, 2013
Noa E-Mailed - Sou Required From Applicant
Mar 19, 2013
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2013
Published For Opposition
Feb 27, 2013
Notification Of Notice Of Publication E-Mailed
Feb 11, 2013
Law Office Publication Review Completed
Feb 11, 2013
Approved For Pub - Principal Register
Feb 11, 2013
Data Modification Completed
Feb 11, 2013
Assigned To Lie
Jan 31, 2013
Teas/Email Correspondence Entered
Jan 30, 2013
Correspondence Received In Law Office
Jan 30, 2013
Teas Response To Suspension Inquiry Received
Jan 16, 2013
Notification Of Letter Of Suspension E-Mailed
Jan 16, 2013
Letter Of Suspension E-Mailed
Jan 16, 2013
Suspension Letter Written
Jan 16, 2013
Assigned To Examiner
Sep 22, 2012
New Application Office Supplied Data Entered In Tram
Sep 22, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
